/주식/RMTI
RMTI

RMTI

USD

Rockwell Medical Inc. Common Stock

$1.230+0.020 (1.653%)

실시간 가격

Healthcare
Drug Manufacturers - Specialty & Generic
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.210

고가

$1.310

저가

$1.200

거래량

0.07M

기업 기본 정보

시가총액

42.0M

산업

Drug Manufacturers - Specialty & Generic

국가

United States

거래 통계

평균 거래량

0.26M

거래소

NCM

통화

USD

52주 범위

저가 $0.86현재가 $1.230고가 $5.15

AI 분석 리포트

마지막 업데이트: 2025년 5월 2일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

RMTI: Rockwell Medical Inc. Common Stock - What's Going On and What Might Be Next

Stock Symbol: RMTI Generate Date: 2025-05-02 10:43:32

Alright, let's break down what's been happening with Rockwell Medical (RMTI) and see what the data might be hinting at. Think of this as chatting about the stock over coffee.

What's Been Happening? (News & Price Check)

First off, the news flow has been pretty light lately. We know the company plans to share its first-quarter results on May 12th. That's just an announcement for now, but earnings reports can definitely shake things up, sometimes for the better, sometimes not. It's a date to circle on the calendar if you're watching this stock.

The other notable piece of news came out back in late March. An analyst over at HC Wainwright & Co. kept their "Buy" rating on RMTI, which sounds good on the surface. But here's the catch: they slashed their price target from a hopeful $7 all the way down to $3. That's a pretty big cut, and it tells us that even though they still think the stock could go up, they see a much lower ceiling for it than before. That kind of move from an analyst can definitely weigh on investor sentiment.

Now, let's look at the price chart over the last few months. It hasn't been a smooth ride. Back in early February, the stock was trading around $2.00. Since then, it's been on a clear downward slide. There was a particularly sharp drop around late March, right after that analyst news came out. The price has drifted lower since then, hitting a low point around $0.86 in early April. More recently, it seems to have found a bit of a floor, bouncing around between roughly $1.00 and $1.20. As of yesterday, it closed right around $1.08.

Looking Ahead (AI & Potential Moves)

So, where does that leave us? The AI prediction model we're looking at offers a little glimmer of potential short-term upside from here. It's forecasting the price to stay flat today (0.00% change), but then tick up slightly by 2.49% tomorrow and another 3.49% the day after. It even mentions a potential target price of $1.03, which seems a bit odd given the current price is $1.08 and it predicts increases, but the overall direction it's pointing for the next couple of days is slightly positive.

Putting the news, price action, and AI prediction together, it's a bit of a mixed picture, but with some clear caution flags. The long-term price trend has been down, and that analyst target cut is a significant negative signal. However, the stock seems to have stabilized recently, and the AI is predicting a small bounce from the current level.

Given the sharp drop already and the AI's short-term forecast, the situation might suggest a 'hold' if you're already in, or perhaps a cautious look for those considering getting in, but only if you're comfortable with the risks. The analyst's lowered target can't be ignored.

If someone were thinking about potentially getting into this stock based on the recent stability and the AI's short-term positive outlook, the current price area around $1.08 could be a point of interest. It seems to be acting as a recent support level.

Thinking about managing risk is key here. If the price starts to fall again, especially breaking below recent lows, that could signal more trouble. The data suggests a potential stop-loss level around $0.97. On the flip side, if the AI prediction plays out and the stock moves up, a potential area to watch for taking some profits might be around $1.15 or so, based on the provided data's suggestion. Remember, these are just potential levels based on the analysis, not guarantees.

A Bit About the Company

Just to round things out, Rockwell Medical is a healthcare company that makes and sells products used in kidney dialysis. They're a relatively small company with a market value around $37 million and average trading volume isn't huge. Small companies like this can sometimes see bigger price swings, so that's something to keep in mind.


Important Note: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

BusinessWire

Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today

더 보기
Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical with a Buy and lowers the price target from $7 to $3.

더 보기
HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $3

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 5월 4일 오후 03:48

약세중립강세

70.1% 신뢰도

리스크 & 트레이딩

리스크 수준4/5
고위험
적합 대상
공격적
트레이딩 가이드

진입점

$1.23

익절

$1.32

손절

$1.10

핵심 요소

DMI는 약세 추세(ADX:12.8, +DI:22.5, -DI:25.2)를 보여 주의를 요합니다.
현재 가격이 지지선($1.22)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(4,939)의 10.1배로 극도로 강력한 매수 압력을 나타냅니다.
MACD -0.0031이(가) 신호선 -0.0033 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기